Title: Effect of indomethacin on the binding of the chemotactic peptide formyl‐Met—Leu—Phe on human polymorphonuclear leukocytes
Abstract: FEBS LettersVolume 132, Issue 1 p. 85-88 Full-length articleFree Access Effect of indomethacin on the binding of the chemotactic peptide formyl-Met—Leu—Phe on human polymorphonuclear leukocytes Hélène Cost, Hélène Cost Unité 204 de l'INSERM Hôpital Saint-Louis, 2 Place du Docteur Fournier, 75475 Paris Cedex 10, FranceSearch for more papers by this authorChristian Gespach, Christian Gespach Unité 204 de l'INSERM Hôpital Saint-Louis, 2 Place du Docteur Fournier, 75475 Paris Cedex 10, FranceSearch for more papers by this authorJean-Pierre Abita, Corresponding Author Jean-Pierre Abita Unité 204 de l'INSERM Hôpital Saint-Louis, 2 Place du Docteur Fournier, 75475 Paris Cedex 10, FranceTo whom correspondence and reprint requests should be addressedSearch for more papers by this author Hélène Cost, Hélène Cost Unité 204 de l'INSERM Hôpital Saint-Louis, 2 Place du Docteur Fournier, 75475 Paris Cedex 10, FranceSearch for more papers by this authorChristian Gespach, Christian Gespach Unité 204 de l'INSERM Hôpital Saint-Louis, 2 Place du Docteur Fournier, 75475 Paris Cedex 10, FranceSearch for more papers by this authorJean-Pierre Abita, Corresponding Author Jean-Pierre Abita Unité 204 de l'INSERM Hôpital Saint-Louis, 2 Place du Docteur Fournier, 75475 Paris Cedex 10, FranceTo whom correspondence and reprint requests should be addressedSearch for more papers by this author First published: September 14, 1981 https://doi.org/10.1016/0014-5793(81)80433-4Citations: 24AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 W.L. Smith, W.E.M. Lands, J. Biol. Chem., 246, (1971), 6700– 6702. 2 W.E.M. Lands, L.H. Rome, S.M.M. Karim Prostaglandins: Chemical and Biochemical Aspects (1976), MTP London 87– 138. 3 L. Kaplan, J. Weiss, P. Elsbach, Proc. Natl. Acad. Sci. USA, 75, (1978), 2955– 2958. 4 J.T. O'Flaherty, H.J. Showell, E.L. Becker, P.A. Ward, Prostaglandins, 17, (1979), 915– 927. 5 J.E. Smolen, J.E. Weismann, Biochem. Pharmacol., 29, (1980), 533– 538. 6 G.M. Bokoch, P.W. Reed, Biochem. Biophys. Res. Commun, 90, (1979), 481– 487. 7 R.J. Smith, S.S. Iden, Biochem. Pharmacol., 29, (1980), 2389– 2395. 8 S. Aswanikumar, B. Corcoran, E. Schiffmann, A.R. Day, R.J. Feer, H.J. Showell, E.L. Becker, C. Pert, Biochem. Biophys. Res. Commun., 74, (1977), 810– 817. 9 L.T. Williams, R. Snyderman, M.C. Pike, R.J. Lefkowitz, Proc. Natl. Acad. Sci. USA, 74, (1977), 1204– 1208. 10 J.P. Abita, J.L. Morgat, FEBS Lett., 111, (1980), 14– 18. 11 Y.C. Chen, W.H. Prusoff, Biochem. Pharmacol., 22, (1973), 3099– 3108. 12 C. Shin Lia, R.J. Freer, Biochem. Biophys. Res. Commun., 93, (1980), 566– 571. 13 F.A. Kuehl jr, R.W. Egan, Science, 210, (1980), 978– 984. 14 C. Dahinden, J. Fehr, J. Clin. Invest., 66, (1980), 884– 891. 15 D.E. Chenoweth, T.E. Hugli, Proc. Natl. Acad. Sci. USA, 75, (1978), 3943– 3947. 16 R.D. Nelson, S.K. Ackerman, V.D. Fiegel, M.P. Bauman, S.D. Douglas, Infect. Immun., 26, (1979), 996– 999. 17 T.L. Goodfriend, R.U. Simpson, Brit. J. Pharmac., 72, (1981), 247– 255. Citing Literature Volume132, Issue1September 14, 1981Pages 85-88 ReferencesRelatedInformation